Mylan NV develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company was founded in 1961 and is based in Potters Bar, Hertfordshire.
MYL Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for MYL, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Mylan NV ranked in the 75th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 306%. The most interesting components of our discounted cash flow analysis for Mylan NV ended up being:
40% of the company's capital comes from equity, which is greater than merely 16.77% of stocks in our cash flow based forecasting set.
Mylan NV's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 14.9% of tickers in our DCF set.
Relative to other stocks in its sector (Healthcare), Mylan NV has a reliance on debt greater than 91.5% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MYL, try RDNT, CSTL, UHS, CI, and ABBV.
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Reversible Airway Diseases Treatment Market, By Type (Bronchodilators, Cytotoxic Drugs, Antibiotics, Others), Treatment (Chest X Ray, CT Scan, Lung Therapies, Surgery Transplant and Medications), Diseases
Los Angeles, United State, – – QY Research recently added a research report, Global Carboplatin Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Carboplatin market. It highlights the drivers and restraints
The Global Drug Addiction Treatment Market research study takes a comprehensive approach towards studying the key trends influencing the growth of this sector. The report comprises data that offers an in-depth insight into the business sector. The research report focuses
Global Opioids Drug Market Synopsis: The Opioids Drug Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Opioids Drug Market size to maintain the average annual growth rate of 0.83% from $11.1
The Calcium Folinate market 2020 research report is a detailed view of market opportunity by end-user segments, product Type segments, sales channels, key countries. It also provides market credentials such as history, various development and trends, market overview, regional